论文部分内容阅读
目的:观察加味三拗汤联合孟鲁司特钠片治疗咳嗽变异性哮喘的临床疗效。方法:选择咳嗽变异性哮喘患者88例,将其随机分为治疗组46例、对照组42例,对照组给予孟鲁司特钠片治疗,治疗组在对照组基础上加用加味三拗汤治疗,2组治疗时间均为30天。比较2组患者临床疗效,咳嗽缓解以及咳嗽消失时间,随访6月、12月后的复发情况。结果:治疗组总有效率为93.48%,对照组为78.57%,2组比较,差异有统计学意义(P<0.05)。治疗组患者咳嗽缓解时间以及咳嗽消失时间均显著低于对照组(P<0.05)。治疗组患者治疗后6月、12月的复发率均显著低于对照组(P<0.05)。结论:加味三拗汤联合孟鲁司特钠片治疗咳嗽变异性哮喘具有着显著的临床疗效,能够缩短患者病程,同时其长期复发率显著降低,具有一定的临床应用价值。
Objective: To observe the clinical efficacy of Jiawei San’ao Decoction combined with montelukast sodium in the treatment of cough variant asthma. Methods: Eighty-eight patients with cough variant asthma were randomly divided into treatment group (n = 46) and control group (n = 42). The control group was treated with montelukast sodium tablets. The treatment group was given Jiawei San’ao Decoction Treatment, two groups were treated for 30 days. The clinical efficacy, cough relief and disappearance of cough were compared between the two groups, followed up for recurrences after 6 months and 12 months. Results: The total effective rate was 93.48% in the treatment group and 78.57% in the control group. There was significant difference between the two groups (P <0.05). Cough relief time and cough disappearing time in treatment group were significantly lower than those in control group (P <0.05). The recurrence rates of patients in treatment group at 6 and 12 months after treatment were significantly lower than those in control group (P <0.05). Conclusion: Modified San’ao Decoction combined with montelukast sodium tablet has significant clinical curative effect on cough variant asthma, which can shorten the course of patients and reduce the long-term recurrence rate. It has certain clinical value.